In an early trial, a one-size-fits-all vaccine shows promise in preventing hard-to-treat pancreatic cancers from coming back.
One-size-fits-all pancreatic cancer vaccine showed promise in early trial
The vaccine doesn't prevent cancer from happening in the first place, but an early-phase trial found it could reduce the odds of recurrence.